Advertisement
UK markets close in 4 hours 13 minutes
  • FTSE 100

    7,835.43
    -41.62 (-0.53%)
     
  • FTSE 250

    19,282.45
    -168.22 (-0.86%)
     
  • AIM

    741.44
    -3.85 (-0.52%)
     
  • GBP/EUR

    1.1677
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2435
    -0.0003 (-0.02%)
     
  • Bitcoin GBP

    52,217.95
    +1,914.70 (+3.81%)
     
  • CMC Crypto 200

    1,334.40
    +21.78 (+1.69%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    82.03
    -0.70 (-0.85%)
     
  • GOLD FUTURES

    2,392.60
    -5.40 (-0.23%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,717.35
    -120.05 (-0.67%)
     
  • CAC 40

    8,000.38
    -22.88 (-0.29%)
     

How Eli Lilly’s Endocrinology Drugs Are Performing

In 3Q17, Eli Lilly’s (LLY) Humalog generated revenues of $696.2 million, ~9% growth on year-over-year (or YoY) basis and 3% growth on a quarter-over-quarter basis.